Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 9/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 8/20 | 0.35 |
| ▸ | TSHR | P16473 | 8/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 8/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.35 |
| ▸ | PDE5A | O76074 | 1/20 | 0.33 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.32 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL613043 | 1.00 | CYP1A2 (0.35) | CYP1A2CYP2C9TSHRCYP2C19CYP3A4 | |
| SCHEMBL676881 | 0.95 | SOAT2 (0.37) | OXER1SOAT2SOAT1CYSLTR2CYSLTR1 | |
| SCHEMBL676882 | 0.95 | SOAT2 (0.37) | OXER1SOAT2SOAT1CYSLTR2CYSLTR1 | |
| SCHEMBL5209893 | 0.93 | SOAT2 (0.39) | OXER1SOAT2SOAT1CYSLTR2CYSLTR1 | |
| SCHEMBL5207243 | 0.93 | SOAT2 (0.39) | OXER1SOAT2SOAT1CYSLTR2CYSLTR1 | |
| SCHEMBL5206578 | 0.93 | SOAT2 (0.39) | OXER1SOAT2SOAT1CYSLTR2CYSLTR1 | |
| SCHEMBL5207912 | 0.93 | SOAT2 (0.39) | OXER1SOAT2SOAT1CYSLTR2CYSLTR1 | |
| SCHEMBL5204831 | 0.93 | SOAT2 (0.39) | OXER1SOAT2SOAT1CYSLTR2CYSLTR1 | |
| SCHEMBL5206585 | 0.93 | SOAT2 (0.39) | OXER1SOAT2SOAT1CYSLTR2CYSLTR1 | |
| SCHEMBL5204821 | 0.93 | SOAT2 (0.39) | OXER1SOAT2SOAT1CYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2786985-A2 | Antagonists of the glucagon receptor | Metabasis Therapeutics, Inc. (US) | 2014-10-08 | — | — | EP | claimed |
| CN-101610995-A | Novel glucagon receptor antagonists | METABASIS THERAPEUTICS INC (US) | 2009-12-23 | — | — | CN | claimed |
| EP-2129654-A1 | NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR | Metabasis Therapeutics, Inc. (US) | 2009-12-09 | — | — | EP | claimed |
| WO-2008098244-A1 | NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR | METABASIS THERAPEUTICS, INC. (US) | 2008-08-14 | — | — | WO | claimed |
| WO-2024099911-A1 | IRON CARBONYL COMPLEXES WITH CHIRAL, BIDENTATE BIPHOSPHINE LIGANDS | BASF SE (DE) | 2024-05-16 | — | — | WO | disclosed |
| WO-2023137133-A2 | PROCESS FOR THE SELECTIVE CATALYTIC HYDROGENATION OF DIENONES | BASF SE (DE) | 2023-07-20 | — | — | WO | disclosed |
| US-20230012337-A1 | POLYESTERS | CLARIANT INTERNATIONAL LTD. (CH) | 2023-01-12 | — | — | US | disclosed |
| US-RE49036-E1 | Method for synthesizing optically active carbonyl compounds | BASF SE (DE) | 2022-04-19 | — | — | US | disclosed |
| WO-2021116049-A1 | POLYESTERS | CLARIANT INTERNATIONAL LTD (CH) | 2021-06-17 | — | — | WO | disclosed |
| WO-2021118814-A1 | A DETERGENT COMPOSITION COMPRISING A POLYMER | THE PROCTER & GAMBLE COMPANY (US) | 2021-06-17 | — | — | WO | disclosed |
| EP-3835396-A1 | A DETERGENT COMPOSITION COMPRISING A POLYMER | The Procter & Gamble Company (US) | 2021-06-16 | — | — | EP | disclosed |
| US-20210171874-A1 | DETERGENT COMPOSITION COMPRISING A POLYMER | THE PROCTER AND GAMBLE COMPANY | 2021-06-10 | — | — | US | disclosed |
| WO-2003057235-A2 | MODIFICATION OF FEEDING BEHAVIOR | IMPERIAL COLLEGE INNOVATIONS LTD (GB) | 2003-07-17 | — | — | WO | disclosed |
| US-6590071-B1 | Increasing the delivery of hydrophilic amine containing compounds to the cell having a mucosal barrier, in which a compound of given formula penetrates the mucosal barrier of the cell; free amine is liberated by hydrolysis | UNIVERSITY OF SOUTHERN CALIFORNIA | 2003-07-08 | — | — | US | disclosed |
| WO-2003026591-A2 | MODIFICATION OF FEEDING BEHAVIOR | IMPERIAL COLLEGE INNOVATIONS LTD. (GB) | 2003-04-03 | — | — | WO | disclosed |
| WO-2003027637-A2 | ASSESSMENT OF NEURONS IN THE ARCUATE NUCLEUS TO SCREEN FOR AGENTS THAT MODIFY FEEDING BEHAVIOR | OREGON HEALTH AND SCIENCE UNIVERSITY (US) | 2003-04-03 | — | — | WO | disclosed |
| EP-1137631-A1 | REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2001-10-04 | — | — | EP | disclosed |
| US-6100292-A | Ketone derivatives and their medical applications | TORAY INDUSTRIES, INC. (JP) | 2000-08-08 | — | — | US | disclosed |
| WO-2000034236-A1 | REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2000-06-15 | — | — | WO | disclosed |
| EP-0980867-A1 | KETONE DERIVATIVES AND MEDICINAL USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 2000-02-23 | — | — | EP | disclosed |